1,512
Views
20
CrossRef citations to date
0
Altmetric
Research Paper

HPV vaccine recommendation profiles among a national network of pediatric practitioners: understanding contributors to parental vaccine hesitancy and acceptance

, , , &
Pages 1776-1783 | Received 26 Sep 2018, Accepted 11 Dec 2018, Published online: 30 Jan 2019

References

  • Walker, TY, Elam-Evans L, Singleton JA, Yankey D, Markowitz LE, Fredua B, Williams CL, Meyer SA, Stokely S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States 2016. Atlanta (GA): Centers for Disease Control and Prevention; 2017.
  • Niccolai LM, Hansen CE, Credle M, Shapiro ED. Parents’ recall and reflections on experiences related to HPV vaccination for their children. Qual Health Res. 2016;26:842–850. doi:10.1177/1049732315575712.
  • Gilkey MB, Malo TL, Shah PD, Hall ME, Brewer NT. Quality of physician communication about human papillomavirus vaccine: findings from a national survey. Cancer Epidemiol Biomark Prev. 2015;24:1673–1679. doi:10.1158/1055-9965.EPI-15-0326.
  • Gilkey MB, McRee A. Provider communication about HPV vaccination: A systematic review. Hum Vaccine Immunother. 2016;12:1454–1468. doi:10.1080/21645515.2015.1129090.
  • Henrickson NB, Tuzzio L, Gilkey MB, McRee A. You’re never really off time: healthcare providers’ interpretations of optimal timing for HPV vaccination. Preventive Med Rep. 2016;4:94–97. doi:10.1016/j.pmedr.2016.05.002.
  • Garganto LM, Herbert NL, Sales JM, Morfaw C, Rask K. Impact of a physician recommendation and parental immunization attitudes on receipt or intention to receive adolescent vaccines. Hum Vaccine Immunother. 2013;9:2627–2633. doi:10.4161/hv.25823.
  • Kester L, Zimet GD, Fortenberry JD, Kahn JA, Shew ML. A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination. Mater Child Health J. 2013;17:879–885. doi:10.1007/s10995-012-1066-z.
  • Hopfer S, Clippard JR. College women’s HPV vaccine decision narratives. Qual Health Res. 2011;21:262–277. doi:10.1177/1049732310383868.
  • Brown B, Gabra MI, Pellman H. Reasons for acceptance or refusal of Human Papillomavirus vaccine in a California pediatric practice. Papillomavirus Res. 2017;3:42–45. doi:10.1016/j.pvr.2017.01.002.
  • Rimer B, Harper H, Witte O. Accelerating HPV vaccine uptake: urgency for action to prevent cancer. Rockville (MD): NCI; 2014.
  • Donahue KL, Stupiansky NW, Alexander AB, Zimet GZ. Acceptability of the human papillomavirus vaccine and reasons for non-vaccination among parents of adolescent sons. Vaccine. 2015;32:3883–3885. doi:10.1016/j.vaccine.2014.05.035.
  • Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, Curtis RC, Markowitz L. Human papillomavirus vaccination coverage among adolescents, 2007-2013, and post-licensure vaccine safety monitoring, 2006-2014, United States. Atlanta (GA): Centers for Disease Control and Prevention; 2014.
  • Kulczycki A, Shewchuk RM. Primary care physicians’ adherence to guidelines and their likelihood to prescribe HPV vaccine for 11-12 year old girls. Women’s Health Issues. 2016;26(1):34–39. doi:10.1016/j.whi.2015.07.012.
  • Brewer NT, Hall ME, Malo TL, Gilkey MB, Quinn B, Lathren C. Announcements versus conversations to improve HPV vaccination coverage: A randomized trial. Pediatrics. 2017;139:e20161764. doi:10.1542/peds.2016-1764.
  • Collins LM, Lanza ST. Latent class and latent transition analysis: with applications in the social,behavioral, and health sciences. New York (NY): Wiley; 2010.
  • Balk SJ, Gottschlich EA, Holman DM, Watson M. Counseling on sun protection and indoor tanning. Pediatrics. 2017;140(6):e20171680. doi:10.1542/peds.2017-0685.
  • Lanza ST, Collins LM, Lemmon D, Schafer JL. PROC LCA: A SAS procedure for latent class analysis. Struct Equ Modeling. 2007;14:671–694.
  • Walling EB, Benzoni N, Dornfeld J, Bhandari R, Sisk BA, Garbutt J, Colditz G. Interventions to improve HPV vaccine uptake: A systematic review. Pediatrics. 2016;138(1):e20153863. doi:10.1542/peds.2015-3863.
  • Niccolai LM, Pettigrew M. The role of cognitive bias in suboptimal HPV vaccine uptake. Pediatrics. 2016;138(4):e20161537. doi:10.1542/peds.2016-1537.
  • Hopfer S, Ray AE, Hecht ML, Miller-Day M, Belue R, Zimet G, Evans WD, McKee FX. Taking an HPV vaccine research tested intervention to scale in a clinical setting. Transl Behav Med. 2017;8(5):745–752. doi:10.1093/tbm/ibx066.
  • Freed GL, Clark SJ, Butchart AT, Singer DC, Davis MM. Parental vaccine safety concerns in 2009. Pediatrics. 2010;125(4):654–659. doi:10.1542/peds.2009-1962.
  • Gowda C, Dempsey A. The rise (and fall?) of parental vaccine hesitancy. Hum Vaccin Immunother. 2013;9(8):1755–1762. doi:10.4161/hv.25085.
  • Lanza ST, Bray BC, Collins LM. An introduction to latent class and latent transition analysis. In: Schinka JA, Velicer WF, Weiner IB, editors. Handbook of psychology. Hoboken (New Jersey): Wiley; 2013. p. 691–716.
  • Lanza ST, Flaherty BP, Collins LM. Latent class and latent transition models. In: Schinka JA, Velicer WF, editors. Handbook of health psychology: vo. 2 Research methods in psychology. Hoboken (NJ): Wiley. 2003.
  • Rhoades BL, Greenberg MT, Lanza ST, Blair C. Demographic and familial predictors of early executive function development: contribution of a person-centered perspective. J Exp Child Psychol. 2011;108:638–662. doi:10.1016/j.jecp.2010.08.004.
  • Lanza ST, Rhoades BL. Latent class analysis: an alternative perspective on subgroup analysis in prevention and treatment. Prev Sci. 2011;14(2):157–168. online.
  • Meites E, Kempe A, Markowitz L. Use of a 2-dose schedule for human papillomavirus vaccination - Updated recommendations of the advisory committee on immunization practices. Atlanta (GA): Centers for Disease Control and Prevention; 2016.
  • Sturm L, Donahue KL, Kasting M, Kulkarni A, Brewer NT, Zimet GD. Pediatrician-parent conversations about human papillomavirus vaccination: an analysis of audio recordings. J Adolesc Health. 2017;61:246–251. doi:10.1016/j.jadohealth.2017.02.006.
  • Dempsey A, O’Leary S. Human Papillomavirus Vaccination: narrative review of studies on how providers’ vaccine communication affects attitudes and uptake. Acad Pediatr. 2018;18(2S):S23–S27. doi:10.1016/j.acap.2017.09.001.
  • Mickan S, Burls A, Glasziou P. Patterns of ‘leakage’ in the utilization of clinical guidelines: a systematic review. Postgrad Med J. 2011;87:670–679. doi:10.1136/pgmj.2010.116012.
  • Kepka D, Berkowitz Z, Yabroff KR, Roland K, Saraiya M. Human papillomavirus vaccine practices in the USA: do primary care providers use sexual history and cervical cancer screening results to make HPV vaccine recommendations? Sex Transm Infect. 2012;88(6):433–435. doi:10.1136/sextrans-2011-050437.
  • Schuchat A. The end of human papilloma virus vaccine exceptionalism. Acad Pediatr. 2018;18(2S):S17–S18. doi:10.1016/j.acap.2017.04.022.
  • Crabtree BF, Miller WL, Aita VA, Flocke SA, Strange K. Primary care practice organization and preventive services delivery: a qualitative analysis. J Fam Pract. 1998;46:403–409.
  • Shaw EK, Howard J, West DR, Crabtree BF, Nease DE, Tutt B, Nutting PA. The role of the champion in primary care change efforts. J Am Board Fam Med. 2013;25(5):676–685. doi:10.3122/jabfm.2012.05.110281.
  • Nanagas V, Stolfi A, Nanagas MT, Eberhart GM, Alter SJ. Adolescent male human papillomavirus vaccination. Global Pediatr Health. 2016;3:1–9. doi:10.1177/2333794X16642373.
  • Dempsey A, Cohn L, Dalton V, Ruffin M. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine. 2010;28(4):989–995. doi:10.1016/j.vaccine.2009.10.133.
  • Saslow D, Sienko J, Nkonga M, Brewer NT. Creating a national coalition to increase human papillomavirus vaccination coverage. Acad Pediatr. 2018;18(2S):S11–S13. doi:10.1016/j.acap.2017.06.003.
  • Rosen BL, Shepard A, Kahn JA. US health care clinicians’ knowledge, attitudes, and practices regarding human papillomavirus vaccination: a qualitative systematic review. Acad Pediatr. 2018;18(2S):S53–S65. doi:10.1016/j.acap.2017.10.007.
  • Gilkey MB, Moss JL, Coyne-Beasley T, Hall ME, Shah DP, Brewer NT. Physician communication about adolescent vaccination: how is human papillomavirus vaccine different? Prev Med. 2015;77:181–185. doi:10.1016/j.ypmed.2015.05.024.
  • Cialdini RB, Reno RR. A focus theory of normative conduct: recycling the concept of norms to reduce littering in public places. J Pers Soc Psychol. 1990;58(6):1015–1026. doi:10.1037/0022-3514.58.6.1015.
  • Roberto AJ, Krieger JL, Katz ML, Goei R, Jain P. Predicting Pediatricians’ communication with parents about human papillomavirus (HPV) vaccine: an application of the theory of reasoned action. Health Commun. 2011;26(4):303–312. doi:10.1080/10410236.2010.550021.
  • Holman DM, Bernard V, Roland KB, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014;168:76–82. doi:10.1001/jamapediatrics.2013.2752.
  • Lanza ST, Dziak JJ, Huang L, Xu S, Collins LM. PROC LCA & LTA user’s guide version 1.2.7. University Park, PA: Pennsylvania State University; 2011.
  • Agresti A. Categorical data analysis. Hoboken (NJ): Wiley-Interscience; 2002.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.